1
项与 CD19 CAR-T-Sabz (Sabz Biomedicals) 相关的临床试验Phase I Clinical Trial Evaluating Safety of CD19 CAR-T Cells in Patients With Relapsed or Refractory Acute B-cell Lymphoblastic Leukemia (R/R B-ALL)
This is a single-arm, open-label, phase I study (safety and dose escalation) of autologous Chimeric Antigen Receptor (CAR) T-cells targeting CD19 in patients with relapsed/refractory B cell acute lymphoblastic leukemia (ALL).
100 项与 CD19 CAR-T-Sabz (Sabz Biomedicals) 相关的临床结果
100 项与 CD19 CAR-T-Sabz (Sabz Biomedicals) 相关的转化医学
100 项与 CD19 CAR-T-Sabz (Sabz Biomedicals) 相关的专利(医药)
100 项与 CD19 CAR-T-Sabz (Sabz Biomedicals) 相关的药物交易